Literature DB >> 33399313

Change in Circulating Undercarboxylated Osteocalcin (ucOCN) Is Associated With Fat Accumulation in HIV-Seropositive Women.

Arnold Z Olali1,2, Anjali Sharma3, Qiuhu Shi4, Donald R Hoover5, Kathleen M Weber6, Audrey L French7, Heather S McKay8, Phyllis C Tien9,10, Lena Al-Harthi2, Michael T Yin11, Ryan D Ross1.   

Abstract

BACKGROUND: Bone mineral density loss and fat accumulation are common in people living with HIV. The bone-derived hormone, undercarboxylated osteocalcin (ucOCN) regulates fat metabolism. We investigated the relationship between ucOCN change and body fat change among perimenopausal/postmenopausal HIV-seronegative and HIV-seropositive women on long-term antiretrovirals.
METHODS: Perimenopausal and postmenopausal women enrolled in the Women's Interagency HIV Study MSK substudy underwent trunk and total fat assessment by dual energy x-ray absorptiometry (DXA) at study enrollment (index visit) and again 2 years later. Circulating ucOCN and cOCN were also measured at the index and 2-year visits. The correlation between the 2-year change in ucOCN and cOCN and change in trunk and total fat was assessed as a function of HIV serostatus using linear regression modeling. Multivariate linear regression assessed the association between ucOCN and cOCN change and total and trunk fat change after adjusting for sociodemographic variables. Linear regression models restricted to HIV-seropositive women were performed to examine the contributions of HIV-specific factors (index CD4 count, viral load, and combined antiretroviral therapy use) on the associations.
RESULTS: Increased ucOCN over the 2-year follow-up was associated with less trunk and total fat accumulation in models adjusting for HIV serostatus and participants sociodemographics, whereas there was no association with cOCN and the fat parameters. None of the HIV-specific factors evaluated influenced the association between ucOCN and fat parameters.
CONCLUSION: The current study suggests that increases in ucOCN are associated with decreased fat accumulation in HIV-seronegative and HIV-seropositive postmenopausal women on long-term antiretroviral therapy.
Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33399313      PMCID: PMC7933097          DOI: 10.1097/QAI.0000000000002617

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.771


  55 in total

1.  Comorbidities in Persons With HIV: The Lingering Challenge.

Authors:  Andrea M Lerner; Robert W Eisinger; Anthony S Fauci
Journal:  JAMA       Date:  2020-01-07       Impact factor: 56.272

2.  Rising Obesity Prevalence and Weight Gain Among Adults Starting Antiretroviral Therapy in the United States and Canada.

Authors:  John R Koethe; Cathy A Jenkins; Bryan Lau; Bryan E Shepherd; Amy C Justice; Janet P Tate; Kate Buchacz; Sonia Napravnik; Angel M Mayor; Michael A Horberg; Aaron J Blashill; Amanda Willig; C William Wester; Michael J Silverberg; John Gill; Jennifer E Thorne; Marina Klein; Joseph J Eron; Mari M Kitahata; Timothy R Sterling; Richard D Moore
Journal:  AIDS Res Hum Retroviruses       Date:  2015-09-09       Impact factor: 2.205

3.  The Women's Interagency HIV Study. WIHS Collaborative Study Group.

Authors:  S E Barkan; S L Melnick; S Preston-Martin; K Weber; L A Kalish; P Miotti; M Young; R Greenblatt; H Sacks; J Feldman
Journal:  Epidemiology       Date:  1998-03       Impact factor: 4.822

4.  Change in undercarboxylated osteocalcin is associated with changes in body weight, fat mass, and adiponectin: parathyroid hormone (1-84) or alendronate therapy in postmenopausal women with osteoporosis (the PaTH study).

Authors:  Anne L Schafer; Deborah E Sellmeyer; Ann V Schwartz; Clifford J Rosen; Eric Vittinghoff; Lisa Palermo; John P Bilezikian; Dolores M Shoback; Dennis M Black
Journal:  J Clin Endocrinol Metab       Date:  2011-10-12       Impact factor: 5.958

5.  Long-term body composition changes in antiretroviral-treated HIV-infected individuals.

Authors:  Philip M Grant; Douglas Kitch; Grace A McComsey; Ann C Collier; Benedetta Bartali; Susan L Koletar; Kristine M Erlandson; Jordan E Lake; Michael T Yin; Kathy Melbourne; Belinda Ha; Todd T Brown
Journal:  AIDS       Date:  2016-11-28       Impact factor: 4.177

6.  First line zidovudine/lamivudine/lopinavir/ritonavir leads to greater bone loss compared to nevirapine/lopinavir/ritonavir.

Authors:  Marit G A van Vonderen; Paul Lips; Michiel A van Agtmael; Elly A M Hassink; Kees Brinkman; Suzanne E Geerlings; Jussi Sutinen; Matti Ristola; Sven A Danner; Peter Reiss
Journal:  AIDS       Date:  2009-07-17       Impact factor: 4.177

7.  Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice.

Authors:  Mathieu Ferron; Eiichi Hinoi; Gerard Karsenty; Patricia Ducy
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-24       Impact factor: 11.205

Review 8.  Bone biomarker for the clinical assessment of osteoporosis: recent developments and future perspectives.

Authors:  Tsung-Rong Kuo; Chih-Hwa Chen
Journal:  Biomark Res       Date:  2017-05-18

9.  Repeated Measures Regression in Laboratory, Clinical and Environmental Research: Common Misconceptions in the Matter of Different Within- and between-Subject Slopes.

Authors:  Donald R Hoover; Qiuhu Shi; Igor Burstyn; Kathryn Anastos
Journal:  Int J Environ Res Public Health       Date:  2019-02-11       Impact factor: 3.390

10.  Incidence and Risk Factors for Prediabetes and Diabetes Mellitus Among HIV-infected Adults on Antiretroviral Therapy: A Systematic Review and Meta-analysis.

Authors:  Jobert Richie Nansseu; Jean Joel Bigna; Arnaud D Kaze; Jean Jacques Noubiap
Journal:  Epidemiology       Date:  2018-05       Impact factor: 4.822

View more
  2 in total

1.  Bone and fat hormonal crosstalk with antiretroviral initiation.

Authors:  Arnold Z Olali; Qiuhu Shi; Donald R Hoover; Mariana Bucovsky; Elizabeth Shane; Michael T Yin; Ryan D Ross
Journal:  Bone       Date:  2021-09-20       Impact factor: 4.626

2.  Brief Report: Undercarboxylated Osteocalcin Is Associated With Cognition in Women With and Without HIV.

Authors:  Ryan D Ross; Arnold Z Olali; Qiuhu Shi; Donald R Hoover; Anjali Sharma; Kathleen M Weber; Audrey L French; Heather McKay; Phyllis C Tien; Michael T Yin; Leah H Rubin
Journal:  J Acquir Immune Defic Syndr       Date:  2022-10-01       Impact factor: 3.771

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.